Literature DB >> 26016454

Xijiao Dihuang Decoction () and Rehmannia glutinosa Libosch. protect mice against lipopolysaccharide and tumor necrosis factor alpha-induced acute liver failure.

Yan-Min Liu1, Liu-Luan Zhu2, Rui Li2, Jin-Liang Zhang1, Shan-Shan Yao1, Xiao-Bing Zhou1, Hui Zeng3, Xian-Bo Wang4.   

Abstract

OBJECTIVE: To investigate the hepatoprotective effect of Xijiao Dihuang Decoction (, XJDHD) on lipopolysaccharide (LPS)- and tumor necrosis factor alpha (TNF-α)-induced acute liver failure (ALF) as well as the underlying mechanism of action, and to clarify the key herbs and components of XJDHD.
METHODS: LPS/D-galactosamine (D-GalN) or TNF-α/D-GalN were intraperitoneally injected into C57BL/6J mice to induce ALF. Simultaneously, XJDHD or its individual herbs and components were orally administered. Survival rates, transaminase levels in serum, and hepatic histology were examined to evaluate the effects of XJDHD. The terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay and real-time polymerase chain reaction were additionally performed to expound the mechanism underlying the anti-apoptotic activity of XJDHD.
RESULTS: Oral administration of XJDHD protected mice from lethal liver failure induced by LPS and TNF-α, with notable amelioration of liver injury in histology and a significant decrease in transaminase levels in serum. XJDHD significantly inhibited apoptosis of hepatocytes and enhanced expression of the antiapoptosis genes, c-Flip, Iap1, Gadd45b and A20. In addition, Rehmannia glutinosa Libosch. was identified as the key herb of XJDHD and galactose as the effective component of Rehmannia glutinosa Libosch. that protects against ALF.
CONCLUSIONS: XJDHD inhibits TNF-α-induced apoptosis of hepatocytes by promoting the expression of nuclear factor κ B-regulated anti-apoptotic genes. Rehmannia glutinosa Libosch. is the effective herb of XJDHD and galactose is an active component in this protection.

Entities:  

Keywords:  Chinese medicine; Rehmannia glutinosa Libosch.; Xijiao Dihuang Decoction; acute liver failure; lipopolysaccharides; tumor necrosis factor alpha

Year:  2015        PMID: 26016454     DOI: 10.1007/s11655-015-2141-2

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  5 in total

1.  Investigating the Molecular Mechanism of Xijiao Dihuang Decoction for the Treatment of SLE Based on Network Pharmacology and Molecular Docking Analysis.

Authors:  Fangzhi Wei; Yitian Song; Aiming Gong; Chengdan Pan; Yanping Zhuang; Xuan Zhang; Minyu Zeng
Journal:  Biomed Res Int       Date:  2022-01-20       Impact factor: 3.411

Review 2.  Systematic Review on Chinese Herbal Medicine Induced Liver Injury.

Authors:  Peng Zhang; Yongan Ye; Xianzhao Yang; Yuntao Jiao
Journal:  Evid Based Complement Alternat Med       Date:  2016-08-29       Impact factor: 2.629

3.  Xijiao Dihuang Decoction Alleviates Ischemic Brain Injury in MCAO Rats by Regulating Inflammation, Neurogenesis, and Angiogenesis.

Authors:  Xiaojun Fei; Xu Zhang; Qi Wang; Jingbo Li; Hao Shen; Xuanye Wang; Hongquan Liu; Weiwei Tao
Journal:  Evid Based Complement Alternat Med       Date:  2018-06-25       Impact factor: 2.629

4.  The effects of the Xijiao Dihuang decoction combined with Yinqiao powder on miRNA-mRNA profiles in mice infected with influenza a virus.

Authors:  Ke Li; Xiaoming Chen; Jing Zhong; Hehe Ye; Shujing Zhang; Dongyu Ge; Xudan Wang; Ying Wu
Journal:  BMC Complement Med Ther       Date:  2020-09-21

5.  Efficacy and safety of Xijiao Dihuang decoction in treating Henoch-Schönlein purpura: Study protocol for systematic review.

Authors:  Zhiqian Kong; Jiaming Zheng; Junwei Wu; Jianzhao Ou; Xinyu Zhou; Haiyan Huang
Journal:  Medicine (Baltimore)       Date:  2021-12-23       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.